Published in Biochim Biophys Acta on July 30, 2010
Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. J Immunol (2012) 1.35
Prevalence and predictors of vitamin D insufficiency in children: a Great Britain population based study. PLoS One (2011) 1.25
Therapies for multiple sclerosis: considerations in the pediatric patient. Nat Rev Neurol (2011) 0.93
Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation. Ther Adv Neurol Disord (2012) 0.91
Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis. Ther Adv Neurol Disord (2013) 0.89
Update in vitamin D and multiple sclerosis. Neurosciences (Riyadh) (2015) 0.81
Does sufficient evidence exist to support a causal association between vitamin D status and cardiovascular disease risk? An assessment using Hill's criteria for causality. Nutrients (2014) 0.80
The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D. Dermatoendocrinol (2016) 0.79
The relation between Vitamin D status with fatigue and depressive symptoms of multiple sclerosis. J Res Med Sci (2013) 0.78
Estimated economic benefit of increasing 25-hydroxyvitamin D concentrations of Canadians to or above 100 nmol/L. Dermatoendocrinol (2016) 0.75
A Method for Simultaneous Determination of 25-Hydroxyvitamin D3 and Its 3-Sulfate in Newborn Plasma by LC/ESI-MS/MS after Derivatization with a Proton-Affinitive Cookson-Type Reagent. Mass Spectrom (Tokyo) (2016) 0.75
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol (2011) 25.66
Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology (2007) 4.23
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med (2007) 2.64
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler (2013) 2.20
Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol (2005) 2.16
MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study. Lancet Neurol (2011) 2.12
Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy. Ann Neurol (2010) 1.81
Unusual variants of Alexander's disease. Ann Neurol (2005) 1.76
Treatment optimization in MS: Canadian MS Working Group updated recommendations. Can J Neurol Sci (2013) 1.74
The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported. Pediatrics (2006) 1.50
Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J Immunol (2009) 1.50
Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination. Neurology (2013) 1.44
Hidden focal EEG seizures during prolonged suppressions and high-amplitude bursts in early infantile epileptic encephalopathy. Clin Neurophysiol (2005) 1.39
Epstein-Barr virus in pediatric multiple sclerosis. JAMA (2004) 1.38
Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis. Ann Neurol (2012) 1.32
International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis Rheum (2007) 1.28
Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases. J Immunol (2013) 1.27
2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Ann Neurol (2012) 1.21
Lesion distribution in children with clinically isolated syndromes. Ann Neurol (2008) 1.17
Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis. Curr Opin Neurol (2009) 1.13
Guidelines on the use of intravenous immune globulin for neurologic conditions. Transfus Med Rev (2007) 1.08
Magnetic resonance imaging features of the spinal cord in pediatric multiple sclerosis: a preliminary study. Neuroradiology (2010) 1.07
Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy. Neuron (2013) 1.06
Pediatric multiple sclerosis. Neurologist (2010) 1.04
Update on biomarkers in neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm (2015) 0.96
The management of multiple sclerosis in children: a European view. Mult Scler (2010) 0.95
International Pediatric MS Study Group Clinical Trials Summit: meeting report. Neurology (2013) 0.89
Refractory primary central nervous system vasculitis of childhood: successful treatment with infliximab. J Rheumatol (2012) 0.87
Changes in cognitive performance over a 1-year period in children and adolescents with multiple sclerosis. Neuropsychology (2013) 0.87
Friedreich ataxia presenting as sudden cardiac death in childhood: clinical, genetic and pathological correlation, with implications for genetic testing and counselling. Neuromuscul Disord (2010) 0.87
Epstein-Barr virus in oral shedding of children with multiple sclerosis. Neurology (2013) 0.85
Editors' welcome and a working definition for a multiple sclerosis cure. Mult Scler Relat Disord (2013) 0.83
The demographic, clinical, and magnetic resonance imaging (MRI) features of transverse myelitis in children. J Child Neurol (2011) 0.83
Magnetic resonance imaging of a unique mutation in a family with Pelizaeus-Merzbacher disease. Am J Med Genet A (2010) 0.83
Nocturnal hypoventilation: predictors and outcomes in childhood progressive neuromuscular disease. Arch Dis Child (2010) 0.82
Masquerades of acquired demyelination in children: experiences of a national demyelinating disease program. J Child Neurol (2012) 0.82
Pediatric multiple sclerosis. J Child Neurol (2012) 0.82
The role of the cerebellum in multiple sclerosis. Cerebellum (2015) 0.81
Cerebral arterial and venous blood flow in adolescent multiple sclerosis patients and age-matched controls using phase contrast MRI. J Magn Reson Imaging (2013) 0.81
Diagnosing neuromyelitis optica. Neuroimaging Clin N Am (2013) 0.80
Multiple sclerosis in children. Semin Neurol (2008) 0.80
Pediatric multiple sclerosis: pathobiological, clinical, and magnetic resonance imaging features. Neuroimaging Clin N Am (2013) 0.80
Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis. Mult Scler (2013) 0.80
Subcutaneous interferon Beta-1a in pediatric multiple sclerosis: a retrospective study. J Child Neurol (2013) 0.79
Becker muscular dystrophy caused by an intronic mutation reducing the efficiency of the splice donor site of intron 26 of the dystrophin gene. Neuromuscul Disord (2009) 0.77
Pharmacokinetics, safety and tolerability of miglustat in the treatment of pediatric patients with GM2 gangliosidosis. Mol Genet Metab (2009) 0.77
Treatment of pediatric multiple sclerosis. Curr Treat Options Neurol (2015) 0.77
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials. Neurology (2013) 0.77
Update on emerging therapies for multiple sclerosis. Expert Rev Neurother (2010) 0.77
2010 McDonald criteria in a pediatric cohort: is positivity at onset associated with a more aggressive multiple sclerosis course? Mult Scler (2013) 0.77
Normalization of white matter intensity on T1-weighted images of patients with acquired central nervous system demyelination. J Neuroimaging (2014) 0.76
Coming of age: the use of immunomodulatory therapy in children with multiple sclerosis. Neurology (2005) 0.76
Mosaic microdeletion of 17p11.2-p12 and duplication of 17q22-q24 in a girl with Smith-Magenis phenotype and peripheral neuropathy. Am J Med Genet A (2013) 0.76
Mimics and rare presentations of pediatric demyelination. Neuroimaging Clin N Am (2013) 0.75
Complete deletion of the aprataxin gene: ataxia with oculomotor apraxia type 1 with severe phenotype and cognitive deficit. BMJ Case Rep (2009) 0.75
Lymphohistiocytosis in the brain: recognition of a potentially reversible aspect of primary HLH. Neurology (2012) 0.75
Editors' welcome. Mult Scler Relat Disord (2012) 0.75
Pediatric Demyelination. Continuum (Minneap Minn) (2016) 0.75
Editors' welcome. Mult Scler Relat Disord (2012) 0.75
Editors׳ welcome. Mult Scler Relat Disord (2015) 0.75
Editors' welcome. Mult Scler Relat Disord (2014) 0.75
Editors' welcome. Mult Scler Relat Disord (2015) 0.75
Editors׳ welcome. Mult Scler Relat Disord (2014) 0.75
Editors' welcome. Mult Scler Relat Disord (2015) 0.75
Multiple Sclerosis is a multifaceted disease. Mult Scler Relat Disord (2014) 0.75
Noninfectious central nervous system inflammatory disorders. Semin Pediatr Neurol (2011) 0.75
Pediatric multiple sclerosis. Curr Opin Neurol (2017) 0.75
Editors' Welcome. Mult Scler Relat Disord (2015) 0.75
Editors' Welcome. Mult Scler Relat Disord (2015) 0.75
Editor's Welcome. Mult Scler Relat Disord (2011) 0.75
Editors' welcome. Mult Scler Relat Disord (2014) 0.75
Editors' Welcome. Mult Scler Relat Disord (2016) 0.75
Oral dosing requirements for phenytoin in the first three months of life. J Popul Ther Clin Pharmacol (2010) 0.75
Editors' Welcome. Mult Scler Relat Disord (2016) 0.75
Editors' Welcome. Mult Scler Relat Disord (2015) 0.75
Standardized magnetic resonance imaging acquisition and reporting in pediatric multiple sclerosis. Neuroimaging Clin N Am (2013) 0.75
Editors׳ welcome. Mult Scler Relat Disord (2014) 0.75
Solitary tumefactive demyelinating lesions in children. J Child Neurol (2011) 0.75
Editors' Welcome. Mult Scler Relat Disord (2016) 0.75